What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the role of Ganoderma lucidum polysaccharide (GLP) in improving the formation of cholesterol gallstones (CG) caused by bile acid metabolism disorders and its underlying mechanisms. Specifically, the study aims to determine whether GLP can reduce the formation of cholesterol gallstones in mice induced by a lithogenic diet (LD) by regulating cholesterol and bile acid metabolism, and to explore whether this process depends on the regulation of the farnesoid X receptor (FXR) signaling pathway. ### Research Background - **Cholesterol Gallstone**: It is a common disease. Approximately 90% of gallstone patients worldwide have cholesterol gallstones. Cholecystectomy is the main treatment for gallstones, but it may lead to complications and affect the patient's quality of life. - **Bile Acid Metabolism**: Bile acids are important products of cholesterol metabolism, and excess cholesterol can be eliminated through bile acid metabolism. The imbalance of bile acid metabolism is closely related to the formation of cholesterol gallstones. - **Farnesoid X Receptor (FXR)**: It is a nuclear receptor, mainly expressed in the intestine and liver, and plays a crucial role in regulating cholesterol and bile acid metabolism. The activation of FXR can inhibit the expression of bile acid - synthesizing enzymes and reduce the synthesis of bile acids. ### Research Objectives - **Explore the Role of GLP**: Study the improvement effect of GLP on the formation of cholesterol gallstones in a mouse model induced by a lithogenic diet. - **Reveal the Underlying Mechanisms**: Explore whether GLP affects cholesterol and bile acid metabolism by regulating the FXR signaling pathway, thereby reducing the formation of cholesterol gallstones. ### Main Findings - **GLP Reduces Gallstone Formation**: GLP significantly reduces the formation rate of gallstones in mice induced by a lithogenic diet and decreases the cholesterol saturation index (CSI) in bile. - **Regulate Bile Acid Metabolism**: GLP increases the total bile acid level in bile, while reducing the levels of FXR - agonist bile acids (such as cholic acid and deoxycholic acid) in the intestine and increasing the level of FXR - antagonist bile acid (such as β - muricholic acid). - **Inhibit FXR Signaling Pathway**: GLP inhibits the negative feedback regulation of bile acid synthesis by down - regulating the FXR - FGF15 signal in the intestine and the FXR - SHP signal in the liver, promotes the synthesis of bile acids, and reduces the synthesis and secretion of cholesterol. - **Improve Intestinal Microbiota**: GLP also improves the imbalance of the intestinal flora, reduces the level of hydrogen sulfide (H2S), a bacterial metabolite in serum, and further inhibits the FXR signaling pathway in the liver. ### Conclusion In summary, GLP effectively reduces the formation of cholesterol gallstones by regulating cholesterol and bile acid metabolism, especially in an FXR - dependent manner. These findings provide a scientific basis for using GLP as a potential strategy for preventing cholesterol gallstone disease.

Ganoderma lucidum polysaccharide ameliorates cholesterol gallstone formation by modulating cholesterol and bile acid metabolism in an FXR-dependent manner

Effect of Hepatic NPC1L1 on Cholesterol Gallstone Disease and Its Mechanism

Ganoderma lucidum polysaccharides improve lipid metabolism against high-fat diet-induced dyslipidemia

Ganoderma lucidum protease hydrolyzate on lipid metabolism and gut microbiota in high-fat diet fed rats

Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.

Ganoderma Lucidum Polysaccharide Peptide Alleviates Hepatoteatosis via Modulating Bile Acid Metabolism Dependent on FXR-SHP/FGF.

Polysaccharide peptides from Ganoderma lucidum ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet-fed rats

Astragalus Polysaccharides Ameliorate Diet-Induced Gallstone Formation by Modulating Synthesis of Bile Acids and the Gut Microbiota

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains

Ligusticum Chuanxiong Prevents High‐fat‐diet‐induced Lipid Metabolism Disorder in Mice by Modulating the Genes in the Cholesterol Pathway

Peroxisome Proliferator-Activated Receptor-γ Prevents Cholesterol Gallstone Formation in C57bl Mice by Regulating Bile Acid Synthesis and Enterohepatic Circulation

GLSP and GLSP-derived triterpenes attenuate atherosclerosis and aortic calcification by stimulating ABCA1/G1-mediated macrophage cholesterol efflux and inactivating RUNX2-mediated VSMC osteogenesis

Anti-inflammatory Effects of Ganoderma Lucidum Sterols Via Attenuation of the P38 MAPK and NF-κB Pathways in LPS-induced RAW 264.7 Macrophages

Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice

Investigating the potential mechanism and therapeutic effects of SLXG for cholesterol gallstone treatment

Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers

Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota

Prevention of Gallstones by Lidan Granule: Insight into Underlying Mechanisms Using a Guinea Pig Model

Glutaredoxin 1 Regulates Cholesterol Metabolism and Gallstone Formation by Influencing Protein S-glutathionylation

Synergistic Effects of Chlorogenic Acid and Ganoderma Lucidum Polysaccharide on Hepatic Fat Accumulation

Chaihu Shugan prevents cholesterol gallstone formation by ameliorating the microbiota dysbiosis and metabolic disturbance in mice